ArticleFuture oncology (London, England)Published
Fixed-duration ibrutinib-venetoclax for first-line treatment of patients with chronic lymphocytic leukemia: the REALITY-WW prospective real-world study cohort
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Sulfonamides; Piperidines; Adenine; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Prospective Studies; Aged; Middle Aged; Female; Male; Leukemia, Lymphocytic, Chronic, B-Cell
- PubMed ID
- 41175112
- PubMed Central ID
- PMC12688257
- Open access
- Yes, open
- Added to directory
- Source checked